Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development

被引:296
作者
Nateri, AS
Spencer-Dene, B
Behrens, A
机构
[1] CR UK London Res Inst, Lincolns Inn Fields Labs, Mammalian Genet Lab, London WC2A 3PX, England
[2] CR UK London Res Inst, Lincolns Inn Fields Labs, Expt Pathol Lab, London WC2A 3PX, England
[3] Univ London Imperial Coll Sci Technol & Med, Dept Histopathol, London SW7 2AZ, England
关键词
D O I
10.1038/nature03914
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The proto-oncoprotein c-Jun is a component of the AP-1 transcription factor, the activity of which is augmented in many tumour types(1). An important mechanism in the stimulation of AP-1 function is amino-terminal phosphorylation of c-Jun by the c-Jun N-terminal kinases (JNKs)(2). Phosphorylated c-Jun is biologically more active, partially because it acquires the ability to interact with binding partners. Here we show that phosphorylated c-Jun interacts with the HMG-box transcription factor TCF4 to form a ternary complex containing c-Jun, TCF4 and beta-catenin. Chromatin immunoprecipitation assays revealed JNK-dependent c-Jun - TCF4 interaction on the c-jun promoter, and c-Jun and TCF4 cooperatively activated the c-jun promoter in reporter assays in a beta-catenin-dependent manner. In the Apc(Min) mouse model of intestinal cancer(6), genetic abrogation of c-Jun N-terminal phosphorylation(3) or gut-specific conditional c-jun inactivation(4,5) reduced tumour number and size and prolonged lifespan. Therefore, the phosphorylation-dependent interaction between c-Jun and TCF4 regulates intestinal tumorigenesis by integrating JNK and APC/beta-catenin, two distinct pathways activated by WNT signalling.
引用
收藏
页码:281 / 285
页数:5
相关论文
共 24 条
[1]   Activation of SRF-regulated chromosomal templates by Rho-family GTPases requires a signal that also induces H4 hyperacetylation [J].
Alberts, AS ;
Geneste, O ;
Treisman, R .
CELL, 1998, 92 (04) :475-487
[2]   THE JUN PROTO-ONCOGENE IS POSITIVELY AUTOREGULATED BY ITS PRODUCT, JUN/AP-1 [J].
ANGEL, P ;
HATTORI, K ;
SMEAL, T ;
KARIN, M .
CELL, 1988, 55 (05) :875-885
[3]   Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation [J].
Behrens, A ;
Jochum, W ;
Sibilia, M ;
Wagner, EF .
ONCOGENE, 2000, 19 (22) :2657-2663
[4]   Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver [J].
Behrens, A ;
Sibilia, M ;
David, JP ;
Möhle-Steinlein, U ;
Tronche, F ;
Schütz, G ;
Wagner, EF .
EMBO JOURNAL, 2002, 21 (07) :1782-1790
[5]   Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation [J].
Behrens, A ;
Sibilia, M ;
Wagner, EF .
NATURE GENETICS, 1999, 21 (03) :326-329
[6]   Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential [J].
Bogoyevitch, MA ;
Boehm, I ;
Oakley, A ;
Ketteman, AJ ;
Barr, RK .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2004, 1697 (1-2) :89-101
[7]   A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia [J].
Borsello, T ;
Clarke, PGH ;
Hirt, L ;
Vercelli, A ;
Repici, M ;
Schorderet, DF ;
Bogousslavsky, J ;
Bonny, C .
NATURE MEDICINE, 2003, 9 (09) :1180-1186
[8]   Signal transduction by the JNK group of MAP kinases [J].
Davis, RJ .
CELL, 2000, 103 (02) :239-252
[9]   AP-1: A double-edged sword in tumorigenesis [J].
Eferl, R ;
Wagner, EF .
NATURE REVIEWS CANCER, 2003, 3 (11) :859-868
[10]   Tissue-specific and inducible Cre-mediated recombination in the gut epithelium [J].
El Marjou, F ;
Janssen, KP ;
Chang, BHJ ;
Li, M ;
Hindie, V ;
Chan, L ;
Louvard, D ;
Chambon, P ;
Metzger, D ;
Robine, S .
GENESIS, 2004, 39 (03) :186-193